alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Assessing Health Risks in Consumer

**Products Treye**  **A. Thomas, Ph.D. Directorate**  **for Health**  **Sciences Office**  **of Hazard Identification**  **and Reduction U.S.**  **Consumer Product**  **Safety Commission** 
The views expressed in this presentation are those of the CPSC staff, have not been reviewed or approved by , and may not necessarily reflect the views of the Commission.

# Who is CPSC? • The U.S. Consumer Product Safety Commission is an independent regulatory agency created in 1973. • Mission: To protect the public from unreasonable risk of injury and death associated with consumer products. • Jurisdiction includes thousands of different types of products sold to consumers for personal use in or around the household or school and in recreation.

– Toys, electronic equipment, appliances, clothing/textiles, household cleaners/chemicals, and building materials

# Regulatory Authority • Consumer Product Safety Act (CPSA), 15 U.S.C. § 2051 -2084 • Federal Hazardous Substances Act (FHSA), 15 U.S.C. § 1261 -1278 • Consumer Product Safety Improvement Act of 2008 (CPSIA)

# Definitions of Toxicity • CPSC regulates many chemical hazards under the Federal Hazardous Substances Act (FHSA) (15 U.S.C. §§ 1261 -1278) • Under the FHSA, the term "hazardous substance" is defined as: “Any substance or mixture of substances which (i) is toxic, (ii) is corrosive, (iii) is an irritant, (iv) is a strong sensitizer, (v) is flammable or combustible, or (vi) generates pressure through decomposition, heat, or other means, if such substance or mixture of substances may cause substantial personal injury or substantial illness during or as a proximate result of any customary or reasonably foreseeable handling or use, including reasonably foreseeable ingestion by children."

# Federal Hazardous Substances Act • Risk-based • Includes acute and chronic effects • Reliable human data preferred • Does not require pre-market approval

require pre market approval • Manufacturers ensure that their products are not hazardous & are properly labeled • Hazardous children’s products are banned • Manufacturers must report “substantial product hazards” (CPSA)

# Risk Assessment Paradigm • Hazard Identification

– Is it toxic? 

### • Dose Response Assessment

– How toxic is it?

– What is the acceptable daily intake (ADI)? 

### • Exposure Assessment

– How much contacts your body? 

### • Risk Characterization

– Does the intake exceed the ADI?

# Chronic Hazard Guidelines (CHG) • In 1992, the Commission issued guidelines for assessing chronic hazards under the FHSA • Provides guidance on
– Determining toxicity (e.g., carcinogenicity, neurotoxicity, bioavailability)

– Acceptable Daily Intake (ADI)

– Threshold for uptake into body

– Assessing exposure

– Risk assessment approaches and acceptable risk • Intended to assist manufacturers in complying with the FHSA

# Options • Labeling • Product Recalls • Product Bans • Voluntary Standards • Mandatory Standards • Other

# Contact Information CPSC Website - www.cpsc.gov Questions - tthomas@cpsc.gov
**EXHIBIT
      32.2**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Sierra Health Services, Inc. (the
      Company) on Form 10-Q for the period ending March 31, 2007 as filed with the
      Securities and Exchange Commission on the date hereof (the Report), I, Marc
      R.
      Briggs, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
      Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
      of
      2002, that:




The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.








/s/
      Marc R. Briggs


Marc
      R.
      Briggs


Chief
      Financial Officer


April
      27,
      2007
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEETS AND STATEMENTS OF OPERATIONS FOUND ON PAGES 2 THROUGH 5 OF THE COMPANY'S
FORM 10-QSB FOR THE QUARTER ENDED MARCH 31, 1997
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                          229723
<SECURITIES>                                         0
<RECEIVABLES>                                  1087494
<ALLOWANCES>                                    185000
<INVENTORY>                                     909417
<CURRENT-ASSETS>                               2324774
<PP&E>                                         2419442
<DEPRECIATION>                                 1404373
<TOTAL-ASSETS>                                 3592302
<CURRENT-LIABILITIES>                           680356
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         29705
<OTHER-SE>                                     2442844
<TOTAL-LIABILITY-AND-EQUITY>                   2472549
<SALES>                                        3507398
<TOTAL-REVENUES>                               3507398
<CGS>                                          1489488
<TOTAL-COSTS>                                  4062343
<OTHER-EXPENSES>                                  7806
<LOSS-PROVISION>                                 40000
<INTEREST-EXPENSE>                               13180
<INCOME-PRETAX>                               (562751)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (562751)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (562751)
<EPS-PRIMARY>                                   (.220)
<EPS-DILUTED>                                   (.220)
        

</TABLE>
RESIGNATION


 


BIO-CARBON SOLUTIONS INTERNATIONAL INC


 


(F/K/A ELEMENTAL PROTECTIVE COATINGS INC)


 


To: The Shareholders of Bio-carbon Solutions International Inc


 


I, John S. Wilkes, hereby resign from the Board of Directors of BIO-CARBON SOLUTIONS INTERNATIONAL INC effective immediately.


 


DATED the 23RD day of October, 2011


 



	
/s/ John Wilkes


	 
	
John S Wilkes
EXHIBIT 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002





In
connection with the annual report of Pharma-Bio Serv, Inc. (the
“Company”) on Form 10-K/A for the fiscal year ended
October 31, 2017 as filed with the Securities and Exchange
Commission on the date hereof (the “report”), the
undersigned, Victor Sanchez, Chief Executive Officer of the
Company, and Pedro J Lasanta, Chief Financial Officer of the
Company, each certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that to our knowledge:





1.
 The
report fully complies with the requirements of Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934, as amended;
and


2.
 The information contained in the report fairly
presents, in all material respects, the financial
condition and results of
operation of the Company.








Dated: February 28, 2018





/s/ Victor Sanchez

/s/ Pedro J. LasantaVictor Sanchez
Chief Executive Officer(principal executive officer)

Pedro J. Lasanta
Chief Financial Officer
(principal financial and accounting officer)








This certification accompanies the Form 10-K/A to which it relates,
is not deemed filed with the Securities and Exchange Commission and
is not to be incorporated by reference to any filing of Pharma-Bio
Serv, Inc. under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended (whether made before or
after the date of the Form 10-K/A), irrespective of any general
incorporation language contained in such filing.
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS SCHEDULE  CONTAINS  SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM MEDICAL
DISCOVERIES,  INC. MARCH 31, 2000  FINANCIAL  STATEMENTS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>

<S>                                       <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                             563
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     96,859
<CURRENT-ASSETS>                                97,422
<PP&E>                                         108,521
<DEPRECIATION>                                 (82,099)
<TOTAL-ASSETS>                                 123,844
<CURRENT-LIABILITIES>                        2,521,066
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     9,913,837
<OTHER-SE>                                 (12,311,059)
<TOTAL-LIABILITY-AND-EQUITY>                   123,844
<SALES>                                              0
<TOTAL-REVENUES>                                 7,620
<CGS>                                            2,511
<TOTAL-COSTS>                                   52,070
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              14,632
<INCOME-PRETAX>                                (59,082)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (59,082)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (59,082)
<EPS-BASIC>                                      (0.00)
<EPS-DILUTED>                                    (0.00)


</TABLE>
James Edward MOORE, Jr. v. STATE EX REL. Robert BROUSSARD

2150858

Court of Civil Appeals of Alabama.

February 10, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Kevin Schlemmer 

EAS and Domestic Analysis Division 

U.S. Department of Transportation 

1200 New Jersey A venue, SE 

Washington, D.C. 20590 

Dear Mr. Schlemmer: 

677 Ala Moana Blvd., Suite 1016 

Honolulu, Hawai'i 96816 

Thursday, 29 October 2013 

I wholeheartedly support Makani Kai Air Charter's bid to continue providing scheduled 

air service to Kalaupapa on the island ofMoloka'i. I am the physician who regularly 

travels to Kalaupapa to serve my patients there. Makani Kai Air Charters has flown me to 

Moloka'i for years now, first on their charters, and for the past 2 years on their scheduled 

flights, and I have found their service to be excellent and reliable. 

During the ten years I have served the patients there as faculty of the University of 

Hawai~i School of Medicine, I have flown to Kalaupapa with several other companies, 

and in my opinion Makani Kai Air Charters is the best offering service to that destination. 

The pilots are professionals and the aircraft are maintained in fine condition. 

Richard Schuman, the owner of Makani Kai, is dedicated to excellent customer service, 

and that philosophy is evident in the company's daily operations. This fine company 

should receive your every consideration for providing essential air service to Kalaupapa. 

Thank you for your time and attention! 

Sincerely, 

S. Kalani Brady, MD, MPH, FACP 

Associate Professor, Department ofNative Hawaiian Health 

Department of Medicine 

University ofHawai'i John A. Burns School of Medicine 

.. -.l-_ ... _,.-·-

' : ... ;··
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 20-0181

STATE OF MONTANA,

Plaintiff and Appellee,

v.

JONATHAN JOSEPH PETERSON,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, 

and good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including August 17, 2020, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

July 10 2020

07/10/2020

Case Number: DA 20-0181
**EXHIBIT
      32.1**





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350, AS ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Quarterly Report of COMC, Inc. (the "Company") on Form
      10-QSB for the period ending March 31, 2004 as filed with the Securities and
      Exchange Commission on the date hereof (the "Report"), pursuant to 18 U.S.C.
§
      1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, I,Janice
      B. Fuellhart, Chief Executive Officer of the Company, certify, that to the
      best
      of my knowledge:





|(1) | The
              Report fully complies with the requirements of section 13(a) or 15(d)
              of
              the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | The
              information contained in the Report fairly presents, in all material
              respects, the financial condition and results ofoperations
              of the Company.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




/s/
      Janice B. Fuellhart


-------------------------------


Janice
      B.
      Fuellhart


Chairman,
      Chief Executive Officer and President





June
      22,
      2005





-------------------------





A
      SIGNED
      ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN PROVIDED
      TO
      COMC, INC. AND WILL BE RETAINED BY COMC, INC. AND FURNISHED TO THE SECURITIES
      AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST
Justin Scott AKINS, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-383

District Court of Appeal of Florida, Second District.

Opinion filed December 15, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
10.3


Exhibit 10.3




Written description of the loan agreement with Liang Wei Wang




Loan Agreement Between:




Liang Wei Wang and Advento, Inc.







Terms of the Loan Agreement:




1. Mr. Wang may provide Loans to Advento Inc. from time to time to help pay for company expenses.

2. The Loans are non-interest bearing and payable to Mr. Wang upon demand.

3. Mr. Wang does not have any obligation to provide Loans to Advento and may do so only if he wishes.
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002

In connection with the Form 10-KSB Annual Report of SLM Holdings, Inc.(the Company) for the period ended December 31, 2007, as filed with the Securities and Exchange Commission on the date hereof (the
Report), the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

| | 1. | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                               
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|
| | 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|

|               |  | SLM HOLDINGS, INC.             
|-------------- |  | -------------------------------
|              
|              
|April 15, 2008 |  | By:/s/ Jason Bishara           
|               |  | Jason Bishara                  
|               |  | Principal Executive Officer and
|               |  | Principal Financial Officer    

---
**Exhibit 32**
  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
   Each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q for the quarter ended June 30, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 This 11th day of August, 2004.
 
 /s/ David D. StovallChief Executive Officer/s/ Annette BanksChief Financial Officer
SCWC-16-0000473

IN THE SUPREME COURT OF THE STATE OF HAWAI#I

TED’S WIRING SERVICE, LTD., 

Petitioner-Respondent/Plaintiff-Appellee,

vs.

DEPARTMENT OF TRANSPORTATION, STATE OF HAWAI#I;

Respondent-Petitioner/Defendant-Appellant.

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS

(CAAP-16-0000473; CIV. NO. 13-1-1910)

ORDER ACCEPTING APPLICATION FOR WRIT OF CERTIORARI

(By: Recktenwald, C.J., Nakayama, McKenna, Pollack, and Wilson, JJ.)

Respondent-Petitioner/Defendant-Appellant Department of

Transportation, State of Hawai#i’s application for writ of

certiorari, filed on April 3, 2020, is hereby accepted.

IT IS FURTHER ORDERED that no oral argument will be

heard in this case. Any party may, within ten days and pursuant

to Rule 34(c) of the Hawai#i Rules of Appellate Procedure, move

for retention of oral argument. 

DATED: Honolulu, Hawai#i, June 1, 2020. 

/s/ Mark E. Recktenwald

/s/ Paula A. Nakayama

/s/ Sabrina S. McKenna 

/s/ Richard W. Pollack

/s/ Michael D. Wilson

Electronically Filed

Supreme Court

SCWC-16-0000473

01-JUN-2020

09:49 AM
Charvon WARREN, Appellant, v. STATE of Florida, Appellee.

No. 4D17-3723

District Court of Appeal of Florida, Fourth District.

[February 15, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
**Exhibit 31.1**

CERTIFICATION PURSUANT TO 

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

I, Vicente Wright, 

1. I have reviewed this quarterly reporton Form 10-Q of California Steel Industries, Inc. (the “Registrant”); 

2. Based on my knowledge, this report does not contain anyuntrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present inall material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; 

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrantand we have: 

(a) design such disclosure controls and procedures, or caused such disclosure controls and procedures to bedesigned under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiary is, made known to us by others within that entity, particularly during the period in which this report is beingprepared; 

(b) evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

(c) disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during theRegistrant’s most recent fiscal year that has materially affected, or is reasonable likely to materially affect, the Registrant’s internal control over financial reporting; and 

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or person performing the equivalent function): 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record,process, summarize and report financial information; and 

(b) any fraud, whether or not material, that involves managementor other employees who have a significant role in the Registrant’s internal control over financial reporting. 

Date: July 28, 2008
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

THEODORE W. SIMPSON III,

Plaintiff-Appellant,

 v.

COMPUTER SCIENCES

CORPORATION, a Nevada corporation,

Defendant-Appellee.

No. 17-55502

D.C. No. 

2:15-cv-09997-ODW-AS

MEMORANDUM*

Appeal from the United States District Court

for the Central District of California

Otis D. Wright II, District Judge, Presiding

Submitted August 10, 2018** 

Pasadena, California

Before: CLIFTON and CHRISTEN, Circuit Judges, and RUFE,*** District Judge.

 

FILED

AUG 20 2018

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2).

*** The Honorable Cynthia M. Rufe, United States District Judge for the

Eastern District of Pennsylvania, sitting by designation.
Theodore Simpson appeals the district court’s order granting summary

judgment to Computer Sciences Corporation (“CSC”). We have jurisdiction under

28 U.S.C. § 1291, and we affirm.

Simpson brought claims under the Fair Employment and Housing Act

(“FEHA”) alleging that he was dismissed from his job as a computer technician

because he was diagnosed with prostate cancer. However, there is no dispute that

Simpson was laid off as part of a large-scale Reduction in Force (or “RIF”) and

CSC provided evidence showing that Simpson was identified as a candidate to be

laid off well before his cancer diagnosis. CSC also provided evidence that

Simpson was selected for the RIF as a result of a series of poor performance

reviews, including evidence that, in some respects, Simpson was one of the worstrated and least productive technicians in his facility. 

We therefore affirm the district court’s order granting summary judgment to

CSC. The district court properly concluded that Simpson could not show that CSC

dismissed him because of his cancer diagnosis and Simpson thus failed to establish

a prima facie case of discrimination. In addition, Simpson’s poor performance

reviews provided a legitimate, non-discriminatory basis for his dismissal which

Simpson failed to rebut with evidence of pretext. Finally, Simpson’s claims that

CSC failed to accommodate his disability and failed to engage in an interactive

2
process were also properly dismissed. Because CSC laid Simpson off for a

legitimate, non-discriminatory, and non-pretextual reason, it had no obligation to

accommodate Simpson’s condition or undertake an interactive process to identify a

potential accommodation. Accordingly, we affirm the judgment of the district

court.

The parties shall bear their own costs for this appeal.

AFFIRMED.

3
REGISTRATION

85678-19